Home > Journals > Minerva Pediatrics > Past Issues > Minerva Pediatrica 2019 October;71(5) > Minerva Pediatrica 2019 October;71(5):455-60

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Minerva Pediatrica 2019 October;71(5):455-60

DOI: 10.23736/S0026-4946.16.04731-9

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Antiretroviral therapy in HIV-infected children

Conghai FAN, Fengchao ZHANG , Chao CHEN

Department of Anesthesiology, Xuzhou Children’s Hospital, Xuzhou Medical University, Xuzhou, China



The pediatric highly-active antiretroviral therapy (HAART) has shown enormous progress in recent years but still, a high percentage of children continue to experience treatment failure. The main causes found responsible are the development of drug resistance, inadequate dosing and poor adherence. This review is aimed at exploring the current status of antiretroviral therapy in children with focus on the interaction between disease, drug and patient behavior, all of which are strongly correlated .An overview of HIV viral characteristics and of the available antiretroviral drug classes currently combined to avoid development of resistance has been also discussed.


KEY WORDS: Pediatrics; HIV infections; Highly active antiretroviral therapy

top of page